Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that wild-type N-RAS is overexpressed in BLBCs but not in other breast cancer subtypes. Repressing N-RAS inhibits transformation and tumor growth, whereas overexpression enhances these processes even in preinvasive BLBC cells. We identified N-Ras-responsive genes, most of which encode chemokines; e.g., IL8. Expression levels of these chemokines and N-RAS in tumors correlate with outcome. N-Ras, but not K-Ras, induces IL-8 by binding and activating the cytoplasmic pool of JAK2; IL-8 then acts on both the cancer cells and stromal fibroblasts. Thus, BLBC progression is promoted by increasing activities of wild-type N-Ras, which mediates autocrine/paracrine signaling that can influence both cancer and stroma cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789 · cited 1×
“Oncogenic RAS mutations are among the most-frequent genetic alterations in human tumors—over 30% of all human tumors contain an oncogenic RAS mutation (Pylayeva-Gupta et al., 2011).”
BackgroundA CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085 · cited 2×
“…N-Ras-dependent genes, we found that expression of CXCL1, which encodes a critical factor for linking chemotherapy resistance and metastasis (Acharyya et al., 2012), is also influenced by K-Ras, suggesting that K- and N-Rasmay coordinately regulate another set of genes that are important…”
BackgroundHaigis, K. M., Kendall, K. R., Wang, Y., Cheung, A., Haigis, M. C., Glickman, J. N., Niwa-Kawakita, M., Sweet-Cordero, A., Sebolt-Leopold, J., Shannon, K. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.115 · Cited by 610
Ras signalling on the endoplasmic reticulum and the Golgi
Chiu, V. K., Bivona, T., Hach, A., Sajous, J. B., Silletti, J., Wiener, H., Johnson, R. L., Cox, A. D., & Philips, M. R. (2002) · Nature Cell Biology · doi:10.1038/ncb783 · Cited by 594 · cited 1×
“We and others have shown that, when these proteins are restricted to the cytoplasm by mutating these cysteines, the resulting mutant Ras proteins can still transform cells and interact with cytoplasmic effectors (Cheng et al., 2011; Chiu et al., 2002; Zheng et al., 2012a).”
BackgroundYoung, A., Lou, D., & McCormick, F. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0231 · Cited by 211 · cited 2×
“Alternatively, blockage in proliferation caused by oncogenic Ras-induced stresses, such as DNA damage (Grabocka et al., 2014) and MAP kinase pathway desensitization (Young et al., 2013), can be overcome by wild-type Ras present in the same cell.”
BackgroundKharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., & Bouchal, J. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-41 · Cited by 197 · cited 2×
“(legend continued on next page) 8 Cell Reports 12, 1–14, July 21, 2015 ª2015 The Authors Tumor fibroblasts, called carcinoma-associated fibroblasts (CAFs), are emerging as a key stromal component that can promote tumor progression (Kharaishvili et al., 2014).”
BackgroundFibroblast Hepatocyte Growth Factor Promotes Invasion of Human Mammary Ductal Carcinoma In situ
Jedeszko, C., Victor, B. C., Podgorski, I., & Sloane, B. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1043 · Cited by 104 · cited 2×
“We also examined a preinvasive BLBC cell line, SUM102PT, which was derived from intraductal carcinoma and shows ductal carcinoma in situ (DCIS) features in 3D culture (Jedeszko et al., 2009; Kaur et al., 2012).”
Background
Cited by
A model for RAS mutation patterns in cancers: finding the sweet spot
Li, S., Balmain, A., & Counter, C. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0076-6 · Cited by 384
Zhou, X., Dong, K., & Zhang, S. (2023) · Nature Computational Science · doi:10.1038/s43588-023-00528-w · Cited by 160
Cutano, V., Di Giorgio, E., Minisini, M., Picco, R., Dalla, E., & Brancolini, C. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12503 · Cited by 44
Metadata
- Authors
- Zheng, Z.-Y., Tian, L., Bu, W., Fan, C., Gao, X., Wang, H., Liao, Y.-H., Li, Y., Lewis, M. T., Edwards, D., Zwaka, T. P., Hilsenbeck, S. G., Medina, D., Perou, C. M., Creighton, C. J., Zhang, X. H.-F., & Chang, E. C.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 12
- Issue
- 3
- Pages
- 511-524
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W1505153529
- Cited by
- 64
- References
- 7
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation. https://app.cochat.ai/papers/10.1016/j.celrep.2015.06.044
- The paper
- Zheng, Z.-Y., Tian, L., Bu, W., Fan, C., Gao, X., Wang, H., Liao, Y.-H., Li, Y., Lewis, M. T., Edwards, D., Zwaka, T. P., Hilsenbeck, S. G., Medina, D., Perou, C. M., Creighton, C. J., Zhang, X. H.-F., & Chang, E. C. (2015). Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation. Cell Reports. https://doi.org/10.1016/j.celrep.2015.06.044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.